Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2004 1
2005 2
2007 1
2008 1
2010 1
2011 1
2012 3
2014 2
2015 4
2016 4
2017 5
2018 3
2019 2
2020 5
2021 5
2022 3
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Results by year

Filters applied: . Clear all
Page 1
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
Menon U, Gentry-Maharaj A, Burnell M, Singh N, Ryan A, Karpinskyj C, Carlino G, Taylor J, Massingham SK, Raikou M, Kalsi JK, Woolas R, Manchanda R, Arora R, Casey L, Dawnay A, Dobbs S, Leeson S, Mould T, Seif MW, Sharma A, Williamson K, Liu Y, Fallowfield L, McGuire AJ, Campbell S, Skates SJ, Jacobs IJ, Parmar M. Menon U, et al. Among authors: kalsi jk. Lancet. 2021 Jun 5;397(10290):2182-2193. doi: 10.1016/S0140-6736(21)00731-5. Epub 2021 May 12. Lancet. 2021. PMID: 33991479 Free PMC article. Clinical Trial.
Tumour stage, treatment, and survival of women with high-grade serous tubo-ovarian cancer in UKCTOCS: an exploratory analysis of a randomised controlled trial.
Menon U, Gentry-Maharaj A, Burnell M, Ryan A, Singh N, Manchanda R, Kalsi JK, Woolas R, Arora R, Casey L, Dawnay A, Sharma A, Williamson K, Apostolidou S, Fallowfield L, McGuire AJ, Campbell S, Skates SJ, Jacobs IJ, Parmar MKB. Menon U, et al. Among authors: kalsi jk. Lancet Oncol. 2023 Sep;24(9):1018-1028. doi: 10.1016/S1470-2045(23)00335-2. Lancet Oncol. 2023. PMID: 37657461 Free article. Clinical Trial.
Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Dilley J, Gentry-Maharaj A, Ryan A, Burnell M, Manchanda R, Kalsi J, Singh N, Woolas R, Sharma A, Williamson K, Mould T, Fallowfield L, Campbell S, Skates SJ, McGuire A, Parmar M, Jacobs I, Menon U. Dilley J, et al. Among authors: kalsi j. Gynecol Oncol. 2023 Dec;179:123-130. doi: 10.1016/j.ygyno.2023.11.005. Epub 2023 Nov 18. Gynecol Oncol. 2023. PMID: 37980767 Free article. Clinical Trial.
Improved early detection of ovarian cancer using longitudinal multimarker models.
Whitwell HJ, Worthington J, Blyuss O, Gentry-Maharaj A, Ryan A, Gunu R, Kalsi J, Menon U, Jacobs I, Zaikin A, Timms JF. Whitwell HJ, et al. Among authors: kalsi j. Br J Cancer. 2020 Mar;122(6):847-856. doi: 10.1038/s41416-019-0718-9. Epub 2020 Jan 15. Br J Cancer. 2020. PMID: 31937926 Free PMC article.
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
Menon U, Gentry-Maharaj A, Burnell M, Ryan A, Kalsi JK, Singh N, Dawnay A, Fallowfield L, McGuire AJ, Campbell S, Skates SJ, Parmar M, Jacobs IJ. Menon U, et al. Among authors: kalsi jk. Health Technol Assess. 2023 May 11:1-81. doi: 10.3310/BHBR5832. Online ahead of print. Health Technol Assess. 2023. PMID: 37183782 Free PMC article.
Diagnosis of epithelial ovarian cancer using a combined protein biomarker panel.
Russell MR, Graham C, D'Amato A, Gentry-Maharaj A, Ryan A, Kalsi JK, Whetton AD, Menon U, Jacobs I, Graham RLJ. Russell MR, et al. Among authors: kalsi jk. Br J Cancer. 2019 Sep;121(6):483-489. doi: 10.1038/s41416-019-0544-0. Epub 2019 Aug 7. Br J Cancer. 2019. PMID: 31388184 Free PMC article. Clinical Trial.
Unselected Population Genetic Testing for Personalised Ovarian Cancer Risk Prediction: A Qualitative Study Using Semi-Structured Interviews.
Gaba F, Oxley S, Liu X, Yang X, Chandrasekaran D, Kalsi J, Antoniou A, Side L, Sanderson S, Waller J, Ahmed M, Wallace A, Wallis Y, Menon U, Jacobs I, Legood R, Marks D, Manchanda R. Gaba F, et al. Among authors: kalsi j. Diagnostics (Basel). 2022 Apr 19;12(5):1028. doi: 10.3390/diagnostics12051028. Diagnostics (Basel). 2022. PMID: 35626184 Free PMC article.
The UKCTOCS experience--reasons for hope?
Menon U, Kalsi J, Jacobs I. Menon U, et al. Among authors: kalsi j. Int J Gynecol Cancer. 2012 May;22 Suppl 1:S18-20. doi: 10.1097/IGC.0b013e318251cb47. Int J Gynecol Cancer. 2012. PMID: 22543913 Clinical Trial.
Screening of symptomatic women for ovarian cancer.
Gentry-Maharaj A, Kalsi J, Burnell M, Manchanda R, Menon U. Gentry-Maharaj A, et al. Among authors: kalsi j. Lancet Oncol. 2012 Apr;13(4):e138-9; author reply e139-40. doi: 10.1016/S1470-2045(12)70120-1. Epub 2012 Mar 30. Lancet Oncol. 2012. PMID: 22469121 No abstract available.
Diagnostic routes and time intervals for ovarian cancer in nine international jurisdictions; findings from the International Cancer Benchmarking Partnership (ICBP).
Menon U, Weller D, Falborg AZ, Jensen H, Butler J, Barisic A, Knudsen AK, Bergin RJ, Brewster DH, Cairnduff V, Fourkala EO, Gavin AT, Grunfeld E, Harland E, Kalsi J, Law RJ, Lin Y, Turner D, Neal RD, White V, Harrison S, Reguilon I, Lynch C, Vedsted P; ICBP Module 4 Working Group. Menon U, et al. Among authors: kalsi j. Br J Cancer. 2022 Sep;127(5):844-854. doi: 10.1038/s41416-022-01844-0. Epub 2022 May 26. Br J Cancer. 2022. PMID: 35618787 Free PMC article.
46 results